• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Medtronic Mexico S. De R.L. De CV EVOLUT FX PLUS VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Medtronic Mexico S. De R.L. De CV EVOLUT FX PLUS VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number EVFXPLUS-29
Medical Device Problem Codes Perivalvular Leak (1457); Device Dislodged or Dislocated (2923)
Health Effect - Clinical Codes Foreign Body In Patient (2687); Valvular Insufficiency/ Regurgitation (4449)
Date of Event 07/23/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, following the implant of the transcatheter aortic valve, paravalvular leak (pvl) of unknown severity occurred.A post-implant balloon aortic valvuloplasty (bav) was performed while the patient was rapidly paced.Subsequently, the valve dislodged.Prior to valve dislodgement, the implant depth on the non-coronary cusp (ncc) and left coronary cusp (lcc) was 4 millimeter's (mm).After valve dislodgement, the implant depth on the ncc and lcc was -2 mm.The original valve was left in the sinus, and a second valve was implanted valve-in-valve at an implant depth of 6 mm.It was noted that mild pvl was observed post deployment, but a post-implant bav was not performed.Per the physician, the cause of the dislodgement was due to the post-implant bav and the depth of implant.
 
Additional Manufacturer Narrative
D10.Continuation - concomitant medical devices in use during the event include: medtronic product id: d-evolutfx-2329; product serial/lot number: (b)(6); product type: 0195-heart valves; implant date: not-imp lantable; explant date: na.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX PLUS VALVE
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
Medtronic Mexico S. De R.L. De CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX  22210
Manufacturer (Section G)
Medtronic Mexico S. De R.L. De CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX   22210
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
+353(091)708096
MDR Report Key50060132
Report Number9617601-2026-04667
Device Sequence Number13098824
Product Code NPT
UDI-Device Identifier00763000716141
UDI-Public(01)00763000716141(17)280309(20)01
Combination Product (Y/N)N
Initial Reporter StateDC
Initial Reporter CountryUS
PMA/510(K) Number
P130021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/28/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberEVFXPLUS-29
Device Catalogue NumberEVFXPLUS-29
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/23/2026
Initial Report FDA Received Date07/28/2026
Date Device Manufactured03/10/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age65 YR
Patient SexFemale
-
-